医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

CD20-bispecific antibodies improve response to CD19-CAR T cells in lymphoma in vitro and CLL in vivo models.

广告
第一作者: Berit J,Brinkmann
第一单位: Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.;Molecular Medicine Partnership Unit, Heidelberg, Germany.;Genome Biology, European Molecular Biology Laboratory, Heidelberg, Germany.;Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.;Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.
作者单位: Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.;Molecular Medicine Partnership Unit, Heidelberg, Germany.;Genome Biology, European Molecular Biology Laboratory, Heidelberg, Germany.;Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.;Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany. [1] Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.;Molecular Genetics, German Cancer Research Center, Heidelberg, Germany. [2] Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.;Molecular Medicine Partnership Unit, Heidelberg, Germany.;Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany.;Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.;Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Düsseldorf, Germany. [3] Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.;Molecular Medicine Partnership Unit, Heidelberg, Germany.;Genome Biology, European Molecular Biology Laboratory, Heidelberg, Germany. [4] Molecular Genetics, German Cancer Research Center, Heidelberg, Germany. [5] Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.;Molecular Medicine Partnership Unit, Heidelberg, Germany.;Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.;Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Düsseldorf, Germany. [6] Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.;Molecular Medicine Partnership Unit, Heidelberg, Germany.;Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.;Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Düsseldorf, Germany.;Department of Translational Medical Oncology, National Center for Tumor Diseases, Heidelberg, Germany. [7] Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany. [8] Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany.;German Center for Infection Research, Partner Site Munich, Munich, Germany. [9] Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.;German Cancer Consortium and German Cancer Research Center/National Center for Tumor Diseases, Heidelberg, Germany. [10] Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany. [11] Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.;Molecular Medicine Partnership Unit, Heidelberg, Germany.;Genome Biology, European Molecular Biology Laboratory, Heidelberg, Germany.;Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.;Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Düsseldorf, Germany. [12]
DOI 10.1182/blood.2023022682
PMID 38805637
发布时间 2024-11-04
提交
  • 浏览1
Blood

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷